Uncategorized

ONO Enters into a Definitive Agreement to Acquire Deciphera Pharmaceuticals

ONO Pharmaceutical, Co., Ltd., and Deciphera Pharmaceuticals, Inc. announced that on April 29, 2024, ONO and Deciphera entered into a definitive merger agreement under which ONO will acquire all outstanding shares of Deciphera common stock for US $ 25.60 per share in cash through a tender offer followed by a merger of a wholly owned

ONO Enters into a Definitive Agreement to Acquire Deciphera Pharmaceuticals Read More »

Scroll to Top